A detailed history of David J Yvars Group transactions in Pfizer Inc stock. As of the latest transaction made, David J Yvars Group holds 10,003 shares of PFE stock, worth $267,280. This represents 0.18% of its overall portfolio holdings.

Number of Shares
10,003
Previous 9,954 0.49%
Holding current value
$267,280
Previous $278,000 3.96%
% of portfolio
0.18%
Previous 0.18%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$27.7 - $31.39 $1,357 - $1,538
49 Added 0.49%
10,003 $289,000
Q2 2024

Jul 22, 2024

BUY
$25.26 - $29.6 $251,438 - $294,638
9,954 New
9,954 $278,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track David J Yvars Group Portfolio

Follow David J Yvars Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of David J Yvars Group, based on Form 13F filings with the SEC.

News

Stay updated on David J Yvars Group with notifications on news.